FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to obstetrics and gynecology, and discloses a method for prediction of preeclampsia in pregnant women with gestational diabetes mellitus. Method involves blood testing of pregnant woman and determination of glycated fibronectin level and, in case, if pregnancy is accompanied by left-sided location of the placenta and the sex of the fetus is male, and the fibronectin level is 315 pmol/ml, the development of preeclampsia during pregnancy is predicted. Declared method enables timely preventive therapy that will have a favorable effect on perinatal outcomes and reduced incidence of newborns.
EFFECT: invention can be used in prediction of preeclampsia in pregnant women with gestational diabetes mellitus in the second-third trimester.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREVENTING GESTATIONAL DIABETES MELLITUS IN PREGNANT WOMEN DEPENDING ON GENDER OF FETUS | 2022 |
|
RU2810451C1 |
| METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
| METHOD OF PREDICTING THE RISK OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2800716C1 |
| METHOD FOR PREDICTION OF EARLY AND LATE PREECLAMPSIA | 2018 |
|
RU2693412C1 |
| METHOD OF ABORTION THREAT PREDICTION | 2009 |
|
RU2407015C1 |
| METHOD FOR PREDICTION OF PLACENTAL INSUFFICIENCY IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2554827C1 |
| METHOD FOR PREDICTING ADVERSE PREGNANCY OUTCOMES IN WOMEN WITH TYPE 1 DIABETES MELLITUS IN THE SECOND HALF OF PREGNANCY | 2020 |
|
RU2759076C1 |
| METHOD FOR EARLY PREDICTION OF PLACENTAL INSUFFICIENCY | 2009 |
|
RU2410030C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA WITH UNDERLYING GESTATIONAL DIABETES MELLITUS IN PATIENTS AFTER USING ASSISTED REPRODUCTIVE TECHNOLOGIES | 2023 |
|
RU2821559C1 |
| METHOD FOR EARLY PREDICTION OF FETOPLACENTAL INSUFFICIENCY IN THE BEGINNING OF THE SECOND TRIMESTER OF PREGNANCY | 2019 |
|
RU2749107C2 |
